<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-viruses-12-00177">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Marosi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dufkova</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Forro</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Felde</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Erdelyi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Sirmarova</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Palus</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Honig</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Salat</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Tikos</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin</article-title>
  <source>Vaccine</source>
  <year>2019</year>
  <volume>37</volume>
  <fpage>4724</fpage>
  <lpage>4735</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.05.066</pub-id>
  <pub-id pub-id-type="pmid">29805091</pub-id>
 </element-citation>
</ref>
